A case of adenomyosis with leiomyoma that was effectively treated with relugolix and kamishoyosan add-on therapy
Abstract Background Recently, relugolix, an oral gonadotropin-releasing hormone receptor antagonist, has been considered an effective therapy for leiomyoma based on a phase 3 study in Japanese women. Leiomyoma combined with severe adenomyosis occasionally occurs in perimenopausal women; however, lit...
Guardat en:
| Autors principals: | , , , , , , , , , , |
|---|---|
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
BMC
2021-08-01
|
| Col·lecció: | BMC Women's Health |
| Matèries: | |
| Accés en línia: | https://doi.org/10.1186/s12905-021-01442-x |
| Etiquetes: |
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|